Atlanta, GA–(ENEWSPF)–June 5, 2009.
Summary of Situation
Based on data reported to the CDC by 5 p.m. (ET) on June 4, 2009, there have been 13, 217 confirmed and probable cases of H1N1 influenza reported in 50 states, the District of Columbia and Puerto Rico. The U.S. confirmed death count is 27. Specific data is as follows:
Alabama — 94 cases
Alaska — 3 cases
Arkansas — 9 cases
Arizona — 547 cases and 4 deaths
California — 973 cases
Colorado — 75 cases
Connecticut — 395 cases and 1 death
Delaware — 142 cases
Florida — 247 cases
Georgia — 33 cases
Hawaii — 115 cases
Idaho — 16 cases
Illinois — 1,357 cases and 5 deaths
Indiana — 173 cases
Iowa — 92 cases
Kansas — 92 cases
Kentucky — 96 cases
Louisiana — 134 cases
Maine — 17 cases
Maryland — 89 cases
Massachusetts — 787 cases
Michigan — 298 cases and 1 death
Minnesota — 82 cases
Mississippi — 40 cases
Missouri — 46 cases and 1 death
Montana — 15 cases
Nebraska — 60 cases
Nevada — 128 cases
New Hampshire — 64 cases
New Jersey — 148 cases
New Mexico — 108 cases
New York — 858 cases and 8 deaths
North Carolina — 30 cases
North Dakota — 23 cases
Ohio — 35 cases
Oklahoma — 93 cases
Oregon — 167 cases
Pennsylvania — 299 cases
Rhode Island — 18 cases
South Carolina — 60 cases
South Dakota — 10 cases
Tennessee — 104 cases
Texas — 1,670 cases and 3 deaths
Utah — 461 cases and 2 deaths
Vermont — 9 cases
Virginia — 55 cases and 1 death
Washington — 577 cases and 1 death
Washington, D.C.– 24 cases
West Virginia — 6 cases
Wisconsin — 2,217 cases
Wyoming — 25 cases
Puerto Rico — 1 case.
A New Virus Emerges
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.
It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Since the outbreak began in the United States, an increasing number of U.S. states have reported cases of novel H1N1 influenza with associated hospitalizations and deaths. By June 3, 2009, all 50 states in the United States and the District of Columbia and Puerto Rico were reporting cases of novel H1N1 infection. While nationwide U.S. influenza surveillance systems indicate that overall influenza activity is decreasing in the country at this time, novel H1N1 outbreaks are ongoing in parts of the U.S., in some cases with intense activity.
It’s uncertain at this time how serious or severe this novel H1N1 virus will be in terms of how many people infected will develop serious complications or die or how this new virus may affect the U.S. during its upcoming influenza season in the fall and winter. Because this is a new virus, most people will have little or no immunity against it, and illness may be more severe and widespread as a result. In addition, currently there is no vaccine to protect against this novel H1N1 virus. CDC anticipates that there will be more cases, more hospitalizations and more deaths associated with this new virus.
At this time, most people who have become ill with novel H1N1 in the United States have recovered without requiring medical treatment and have experienced typical flu symptoms.
CDC is continuing to watch the situation carefully, to support the public health response and to gather information about this virus and its characteristics.
CDC continues to take aggressive action to respond to the outbreak. CDC’s response goals are to reduce the spread and severity of illness, and to provide information to help health care providers, public health officials and the public address the challenges posed by this new public health threat.
CDC is issuing updated interim guidance daily in response to the rapidly evolving situation.
CDC has issued interim guidance for clinicians on identifying and caring for patients with novel H1N1, in addition to providing interim guidance on the use of antiviral drugs. Influenza antiviral drugs are prescription medicines (pills, liquid or an inhaler) with activity against influenza viruses, including novel influenza H1N1 viruses. The priority use for influenza antiviral drugs during this outbreak is to treat severe influenza illness, including people who are hospitalized or sick people who are considered at high risk of serious influenza-related complications.
CDC has provided guidance for the public on what to do if they become sick with flu-like symptoms, including infection with novel H1N1. CDC also has issued instructions on taking care of a sick person at home and the use of facemasks and respirators to reduce novel influenza A (H1N1) transmission. Novel H1N1 infection has been reported to cause a wide range of symptoms, including fever, cough, sore throat, body aches, headache, chills and fatigue. In addition, a significant number of people also have reported nausea, vomiting or diarrhea. Everyone should take everyday preventive actions to stop the spread of germs, including frequent hand washing. People who are sick should stay home and avoid contact with others in order to limit further spread of the disease.
CDC has developed a PCR diagnostic test kit to detect this novel H1N1 virus and has now distributed test kits to all states in the U.S. and the District of Columbia and Puerto Rico. The test kits are being shipped internationally as well. This will allow states and other countries to test for this new virus.
The U.S. Government is aggressively taking early steps in the process to manufacture a novel H1N1 vaccine, working closely with manufacturing. CDC has isolated the new H1N1 virus, made a candidate vaccine virus that can be used to create vaccine, and has provided this virus to industry so they can begin scaling up for production of a vaccine, if necessary. Making vaccine is a multi-step process requiring several months to complete.
Strategic National Stockpile
CDC has deployed 25 percent of the supplies in the Strategic National Stockpile (SNS) to all states in the continental United States and U.S. territories. This included antiviral drugs, personal protective equipment, and respiratory protection devices. These supplies and medicines will help states and U.S. territories respond to novel H1N1 virus.
Novel influenza A (H1N1) activity is now being detected through CDC’s routine influenza surveillance systems and reported weekly in FluView. CDC tracks U.S. influenza activity through multiple systems across five categories. While our influenza surveillance systems indicate that overall influenza activity is decreasing in the United States, novel H1N1 outbreaks are ongoing in different parts of the U.S., in some cases with intense activity. Most of the influenza viruses being detected now are novel H1N1 viruses.
Individuals have an important role in protecting themselves and their families.
- Stay informed. Health officials will provide additional information as it becomes available.
- Everyone should take these everyday steps to protect your health and lessen the spread of this new virus:
- Cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it.
- Wash your hands often with soap and water, especially after you cough or sneeze. Alcohol-based hand cleaners are also effective.
- Avoid touching your eyes, nose or mouth. Germs spread this way.
- Try to avoid close contact with sick people.
- If you are sick with a flu-like illness, stay home for 7 days after your symptoms begin or until you have been symptom-free for 24 hours, whichever is longer. This is to keep from infecting others and spreading the virus further.
- Follow public health advice regarding school closures, avoiding crowds and other social distancing measures.